Decoding the structural basis of ligand recognition and biased signaling in the motilin receptor

被引:0
作者
You, Chongzhao [1 ,2 ]
Jiang, Mengting [5 ]
Gao, Tianyu [1 ,3 ,5 ]
Zhu, Zining [4 ]
He, Xinheng [1 ,2 ]
Xu, Youwei [1 ,2 ]
Gao, Yuan [1 ,2 ]
Jiang, Yi [3 ,5 ]
Xu, H. Eric [1 ,2 ,3 ,4 ,5 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[3] Lingang Lab, Shanghai 200031, Peoples R China
[4] Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210046, Peoples R China
[5] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China
来源
CELL REPORTS | 2025年 / 44卷 / 03期
关键词
SMALL-MOLECULE AGONISTS; DESENSITIZATION; ERYTHROMYCIN; AZITHROMYCIN; DERIVATIVES; MACROLIDES; DISCOVERY; FEATURES; AMBER;
D O I
10.1016/j.celrep.2025.115329
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The motilin receptor (MTLR) is a key target for treating gastrointestinal (GI) disorders like gastroparesis, yet developing effective agonists remains challenging due to drug tolerance and signaling bias. We present cryoelectron microscopy (cryo-EM) structures of MTLR bound to azithromycin, a macrolide antibiotic, and DS- 3801b, a non-macrolide agonist. Distinct ligand recognition mechanisms are revealed, with azithromycin binding deeply within the orthosteric pocket and DS-3801b adopting a special clamp-like conformation stabilized by a water molecule. We also highlight the critical role of extracellular loop 2 (ECL2) in ligand specificity and signaling pathway activation, affecting both G-protein and b-arrestin signaling. Additionally, the "D2.60R2.63S3.28"motif and interactions around transmembranes 6/7 (TM6/7) are identified as key drivers of signaling selectivity. These findings offer insights into the structural dynamics of MTLR, laying the groundwork for the rational design of next-generation GI prokinetic drugs with enhanced efficacy and safety.
引用
收藏
页数:17
相关论文
共 70 条
  • [1] Erythromycin, clarithromycin, and azithromycin: Are the differences real?
    Amsden, GW
    [J]. CLINICAL THERAPEUTICS, 1996, 18 (01) : 56 - 72
  • [2] Bile acids as endogenous etiologic agents in gastrointestinal cancer
    Bernstein, Harris
    Bernstein, Carol
    Payne, Claire M.
    Dvorak, Katerina
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (27) : 3329 - 3340
  • [3] Functional gastrointestinal disorders: advances in understanding and management
    Black, Christopher J.
    Drossman, Douglas A.
    Talley, Nicholas J.
    Ruddy, Johannah
    Ford, Alexander C.
    [J]. LANCET, 2020, 396 (10263) : 1664 - 1674
  • [4] RQ-00201894: A motilin receptor agonist causing long-lasting facilitation of human gastric cholinergically-mediated contractions
    Broad, John
    Takahashi, Nobuyuki
    Tajimi, Masaomi
    Sudo, Masaki
    Goralczyk, Adam
    Parampalli, Umesh
    Mannur, Kesava
    Yamamoto, Toshinori
    Sanger, Gareth J.
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (02) : 60 - 65
  • [5] The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin
    Broad, John
    Sanger, Gareth J.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2013, 168 (08) : 1859 - 1867
  • [6] Clinical Guideline: Management of Gastroparesis
    Camilleri, Michael
    Parkman, Henry P.
    Shafi, Mehnaz A.
    Abell, Thomas L.
    Gerson, Lauren
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (01) : 18 - 37
  • [7] Erythromycin derivatives ABT 229 and GM 611 act on motilin receptors in the rabbit duodenum
    Clark, MJ
    Wright, T
    Bertrand, PP
    Bornstein, JC
    Jenkinson, KM
    Verlinden, M
    Furness, JB
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (03) : 242 - 245
  • [8] Hydroxyl Groups in Synthetic and Natural-Product-Derived Therapeutics: A Perspective on a Common Functional Group
    Cramer, Jonathan
    Sager, Christoph P.
    Ernst, Beat
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (20) : 8915 - 8930
  • [9] Motilin: from gastric motility stimulation to hunger signalling
    Deloose, Eveline
    Verbeure, Wout
    Depoortere, Inge
    Tack, Jan
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (04) : 238 - 250
  • [10] A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of DS-3801b, a Motilin Receptor Agonist, in Healthy Subjects
    Dennie, Justin
    Atiee, George
    Warren, Vance
    Tao, Ben
    Morimoto, Kiyoshi
    Senaldi, Giorgio
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (09) : 1221 - 1230